Copper efflux transporters ATP7A and ATP7B: Novel biomarkers for platinum drug resistance and targets for therapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Copper efflux transporters ATP7A and ATP7B: Novel biomarkers for platinum drug resistance and targets for therapy
Authors
Keywords
-
Journal
IUBMB LIFE
Volume 70, Issue 3, Pages 183-191
Publisher
Wiley
Online
2018-02-03
DOI
10.1002/iub.1722
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association between polymorphisms in CTR1, CTR2, ATP7A, and ATP7B and platinum resistance in epithelial ovarian cancer
- (2017) Tailin Li et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- A Role for The ATP7A Copper Transporter in Tumorigenesis and Cisplatin Resistance
- (2017) Sha Zhu et al. Journal of Cancer
- Pharmacogenomics of platinum-based chemotherapy sensitivity in NSCLC: toward precision medicine
- (2016) Ji-Ye Yin et al. PHARMACOGENOMICS
- Cisplatin resistance and opportunities for precision medicine
- (2016) Lauren Amable PHARMACOLOGICAL RESEARCH
- Ammonium tetrathiomolybdate treatment targets the copper transporter ATP7A and enhances sensitivity of breast cancer to cisplatin
- (2016) Cristine L. Chisholm et al. Oncotarget
- The role of copper transporter ATP7A in platinum-resistance of esophageal squamous cell cancer (ESCC)
- (2016) Zhuang-hua Li et al. Journal of Cancer
- Mechanistic basis of a combination d-penicillamine and platinum drugs synergistically inhibits tumor growth in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo
- (2015) Szu-Jung Chen et al. BIOCHEMICAL PHARMACOLOGY
- Targeting drug transport mechanisms for improving platinum-based cancer chemotherapy
- (2015) Helen HW Chen et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Copper-transporting ATPases: The evolutionarily conserved machineries for balancing copper in living systems
- (2015) Magdalena Migocka IUBMB LIFE
- Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy
- (2015) Karolina Tecza et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting copper in cancer therapy: ‘Copper That Cancer’
- (2015) Delphine Denoyer et al. Metallomics
- Pharmacogenomics in the clinic
- (2015) Mary V. Relling et al. NATURE
- Carboplatin/taxane-induced gastrointestinal toxicity: a pharmacogenomics study on the SCOTROC1 trial
- (2015) Y J He et al. PHARMACOGENOMICS JOURNAL
- Expression of the copper transporters hCtr1, ATP7A and ATP7B is associated with the response to chemotherapy and survival time in patients with resected non-small cell lung cancer
- (2015) TIAN YANG et al. Oncology Letters
- Cisplatin handover between copper transporters: the effect of reducing agents
- (2014) Angela Galliani et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- The ATP7B genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients
- (2014) Xiang-Ping Li et al. TUMOR BIOLOGY
- Translocation of Platinum Anticancer Drugs by Human Copper ATPases ATP7A and ATP7B
- (2013) Francesco Tadini-Buoninsegni et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Copper chaperone Atox1 interacts with the metal-binding domain of Wilson's disease protein in cisplatin detoxification
- (2013) Nataliya V. Dolgova et al. BIOCHEMICAL JOURNAL
- The role of metal binding and phosphorylation domains in the regulation of cisplatin-induced trafficking of ATP7B
- (2013) Roohangiz Safaei et al. Metallomics
- Role of metal in folding and stability of copper proteins in vitro
- (2012) Maria E. Palm-Espling et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Structural models of the human copper P-type ATPases ATP7A and ATP7B
- (2012) Pontus Gourdon et al. BIOLOGICAL CHEMISTRY
- Role of the Human High-Affinity Copper Transporter in Copper Homeostasis Regulation and Cisplatin Sensitivity in Cancer Chemotherapy
- (2012) M. T. Kuo et al. CANCER RESEARCH
- Membrane Transporters as Determinants of the Pharmacology of Platinum Anticancer Drugs
- (2012) Johnson J. Liu et al. CURRENT CANCER DRUG TARGETS
- The CXXC motifs in the metal binding domains are required for ATP7B to mediate resistance to cisplatin
- (2012) Roohangiz Safaei et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Copper-transporting P-type adenosine triphosphatase (ATP7A) is associated with platinum-resistance in non-small cell lung cancer (NSCLC)
- (2012) Zhuang-hua Li et al. Journal of Translational Medicine
- Overcoming Platinum Resistance through the Use of a Copper-Lowering Agent
- (2012) Siqing Fu et al. MOLECULAR CANCER THERAPEUTICS
- Wilson Disease: Pathogenesis and Clinical Considerations in Diagnosis and Treatment
- (2011) Richard Rosencrantz et al. SEMINARS IN LIVER DISEASE
- ATP7B expression is associated with in vitro sensitivity to cisplatin in non-small cell lung cancer
- (2010) YOSHIMASA INOUE et al. Oncology Letters
- Association of ATP7A expression and in vitro sensitivity to cisplatin in non-small cell lung cancer
- (2010) YOSHIMASA INOUE et al. Oncology Letters
- The soluble metal-binding domain of the copper transporter ATP7B binds and detoxifies cisplatin
- (2009) Nataliya V. Dolgova et al. BIOCHEMICAL JOURNAL
- Therapeutic Targeting of ATP7B in Ovarian Carcinoma
- (2009) L. S. Mangala et al. CLINICAL CANCER RESEARCH
- Human copper transporters: mechanism, role in human diseases and therapeutic potential
- (2009) Arnab Gupta et al. Future Medicinal Chemistry
- Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin-based chemotherapy
- (2009) Eva Martinez-Balibrea et al. INTERNATIONAL JOURNAL OF CANCER
- Functional Interactions of Cu-ATPase ATP7B with Cisplatin and the Role of ATP7B in the Resistance of Cells to the Drug
- (2009) Karoline Leonhardt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Copper Transport in Mammalian Cells: Special Care for a Metal with Special Needs
- (2009) Jack H. Kaplan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells
- (2008) Ganna V Kalayda et al. BMC CANCER
- Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
- (2008) Anshul Gupte et al. CANCER TREATMENT REVIEWS
- The use of copper-lowering therapy with tetrathiomolybdate in medicine
- (2008) George J Brewer EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Platinum compounds 30 years after the introduction of cisplatin: Implications for the treatment of ovarian cancer
- (2008) Franco Muggia GYNECOLOGIC ONCOLOGY
- Neonatal Diagnosis and Treatment of Menkes Disease
- (2008) Stephen G. Kaler et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy
- (2007) Matthew D. Hall et al. Annual Review of Pharmacology and Toxicology
- ATP7B antisense oligodeoxynucleotides increase the cisplatin sensitivity of human ovarian cancer cell line SKOV3ipl
- (2007) W. XU et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started